Abk�rzung zur Hauptnavigation Abk�rzung zu den Newsmeldungen Abk�rzung zu den Topstories  
Deutsche Version Deutsche Version
  MedUni Vienna    Intranet    MedUni Vienna - Shop    University Library    University Hospital Vienna  
 
Krebsforschung_EN.png
 
 
 
Hauptnavigation
  • Home
  • General Information
    • History
    • 50 years Institute for Cancer Research
    • Imagevideo: Institute for Cancer Research
  • Research
    • Research Focus
    • Research Laboratories
    • Scientific Services - Core Facilities
  • Teaching
    • Lectures of the Institute of Cancer Research
    • University Course Toxicology for Postgraduates
    • PhD Program Inflammation and Immunity
    • PhD Program IPPTO Translational Oncology
    • PhD Program Malignant Diseases
    • PhD Program Clinical and Experimental Oncology
  • Contact
    • Contact
    • Map
 
Research / Research Focus / Cellular and Molecular Tumorbiology / Robert Eferl
 
Subnavigation
  • Research Focus
    • Cellular and Molecular Tumorbiology
      • Maria Sibilia
      • Thomas Bauer
      • Robert Eferl
        • Research Projects
        • Group Members
      • Andrea Gsur
      • Erich Heidenreich
      • Dietmar Herndler-Brandstetter
      • Kazuhiko Matsuoka
      • Ferdinand Steinböck
      • Thomas Vogl
    • Applied and Experimental Oncology
    • Chemical Safety and Cancer Prevention
    • Tumor Progression and Metastasis
  • Research Laboratories
  • Scientific Services - Core Facilities


Inhaltsbereich

 

Robert Eferl, Assoc. Prof. Priv.-Doz. Mag. Dr.
Group Leader
E-Mail: robert.eferl [at] meduniwien [dot] ac [dot] at
Phone: +43 (0)1 40160 - 57571
Fax: +43 (0)1 40160 - 957510

Research Focus

We are working on two topics:
1) We identify cooperative signaling pathways in cancer formation using novel mouse models.
2) We focus on functions of STAT transcription factors in inflammatory liver damage and cancer types that are associated with inflammation (also at: www.jak-stat.at)

Group Members

Videos

Selected Publications

STAT1 is a sex-specific tumor suppressor in colitis-associated colorectal cancer.
Crnčec I, Modak M, Gordziel C, Svinka J, Scharf I, Moritsch S, Pathria P, Schlederer M, Kenner L, Timelthaler G, Müller M, Strobl B, Casanova E, Bayer E, Mohr T, Stöckl J, Friedrich K, Eferl R.
Mol Oncol. 2018 Apr;12(4):514-528. doi: 10.1002/1878-0261.12178

Epidermal growth factor signaling protects from cholestatic liver injury and fibrosis.
Svinka J, Pflügler S, Mair M, Marschall HU, Hengstler JG, Stiedl P, Poli V, Casanova E, Timelthaler G, Sibilia M, Eferl R.
J Mol Med (Berl). 2017 Jan;95(1):109-117. doi: 10.1007/s00109-016-1462-8.

Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice.
Pathria P, Gotthardt D, Prchal-Murphy M, Putz EM, Holcmann M, Schlederer M, Grabner B, Crncec I, Svinka J, Musteanu M, Hoffmann T, Filipits M, Berger W, Poli V, Kenner L, Bilban M, Casanova E, Müller M, Strobl B, Bayer E, Mohr T, Sexl V, Eferl R.
Oncoimmunology. 2015 Jan 22;4(4):e998529. eCollection 2015

A mouse model to identify cooperating signaling pathways in cancer.
Musteanu M, Blaas L, Zenz R, Svinka J, Hoffmann T, Grabner B, Schramek D, Kantner HP, Müller M, Kolbe T, Rülicke T, Moriggl R, Kenner L, Stoiber D, Penninger JM, Popper H, Casanova E, Eferl R.
Nat Methods. 2012 Sep;9(9):897-900. doi: 10.1038/nmeth.2130

STAT3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
Mair M, Zollner G, Schneller D, Musteanu M, Fickert P, Gumhold J, Schuster C, Fuchsbichler A, Bilban M, Tauber S, Esterbauer H, Kenner L, Poli V, Blaas L, Kornfeld JW, Casanova E, Mikulits W, Trauner M, Eferl R.
Gastroenterology. 2010 Jun;138(7):2499-508. doi: 10.1053/j.gastro.2010.02.049.

 

All Publications

www.ncbi.nlm.nih.gov/pubmed

 
Print
 
 
© MedUni Wien | Publishing information | Terms of use | Data Protection | Accessibility | Contact